HOME >> MEDICINE >> NEWS
NIAID Stops AIDS Study Prematurely Because Drug 'Cocktail' Boosts Survival

dicine and director of the AIDS unit; Dr. David Wohl, research fellow in medicine; and research clinician Janet Groves.

Nationwide, researchers found 63 "disease progression events" -- including AIDS-related illnesses and deaths among patients receiving a combination of ZDV and 3TC, Eron said. Among patients receiving those two drugs and indinavir, they found only 33 such events.

"There were 18 deaths in the double-therapy arm of the study vs. eight deaths in the triple- therapy arm," he said. "No major differences were found in either safety or toxicity between the two treatments, and study medications were well-tolerated."

Indinavir, a protease inhibitor, works by preventing protease enzymes from cutting up proteins needed to form viruses, Eron explained. The envelope, or outer coating, of the virus still develops, but the core cannot, and therefore the resulting virus is not infectious.

Drugs such as ZDV and 3TC work by inhibiting an enzyme called reverse transcriptase. That enzyme enables the virus' genetic material, or RNA, to convert human genetic material known as DNA into more virus.

The Food and Drug Administration approved use of the combined ZDV and 3TC in November 1995, in part because of a national study Eron led and published in the New England Journal of Medicine. Indinavir has been approved for about a year.

"The people who should be thanked and congratulated for this study and others like it are the people who participated in the trials," Eron said. "They not only have done something that will improve their own care, but they have volunteered to do something that will clearly improve the care of many patients afterwards.

"Treatment with the triple-drug therapy is not easy because of the large number of pills patients have to take and the commitment they have to make to stick to the therapy," he said. "They are the real heroes here."

Glaxo-Wellcome Inc. of Research Triangle Park
'"/>

Contact: David Williamson
rdtokids@email.unc.edu
919-962-2091
University of North Carolina at Chapel Hill
25-Feb-1997


Page: 1 2 3

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
9. NIAID rotavirus vaccine licensed for commercialization
10. Second NIAID SARS vaccine candidate helps mice fend off SARS
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
(Date:2/26/2015)... 2015 A Beautiful Smile Dentistry is ... offering the following 50 year celebration specials to their ... of Sonic Care Diamond Clean or the Braun Oral ... The cost is $2895 for the Invisalign special (this ... ten treatment procedures are priced accordingly). The practice ...
(Date:2/26/2015)... 2015 2015 marks five years of ... David Caggiano! , Orthodontics is a perfect blend ... his background in biomedical engineering, his artistic talent, his ... general dentist allows Dr. Caggiano to create innovative approaches ... was named Orthodontic Products’ Best of 2012, a national ...
(Date:2/26/2015)... 2015 The hip resurfacing procedure ... Central Texas resident John Short to resume his active lifestyle, ... out to climb Mt. Kilimanjaro, the highest free-standing mountain in ... , Starting in his late 20s, Short suffered from early ... bones and sockets were bone on bone. , Then ...
(Date:2/26/2015)... Beckman Coulter is sponsoring a new ... cargo in cell-to-cell communication,” which will focus on the ... communication. The webinar is free to attend and will ... , Every cell in the body can release several ... “exosomes” or “microvesicles.” These vesicles carry a wide array ...
(Date:2/26/2015)... Dallas, Texas (PRWEB) February 26, 2015 ... Hemostat Industry is a professional and in-depth study ... Hemostat industry with a focus on the ... market research are Lawton Gmbh & Co.KG, Hu-Friedy, ... Shanghai Medical Instruments, Shuangyin, Shanghai Weirong Medical Equipment, ...
Breaking Medicine News(10 mins):Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3
(Date:2/26/2015)... -- Mail-service and specialty pharmacies will save ... plans $23.3 billion over the next decade, according ... Association (PCMA). "Home delivery of traditional ... ways to reduce health costs," said PCMA President ... resist efforts to restrict these cost-saving tools." ...
(Date:2/26/2015)... 2015  BD Life Sciences, a segment of ... BDX ), a leading global medical technology company, ... enabling high-resolution biology, today announced that they will ... multiplexed cell isolation and single-cell gene expression analysis. ... BD FACS™ single-cell sorting instrumentation and software with ...
(Date:2/26/2015)... SOUTH SAN FRANCISCO, Calif. , Feb. 26, 2015 ... of a Series A financing round totaling $20.4 million. ... and Third Point Ventures, includes participation by Aperture Venture ... company co-founded in 2013 by David Wurtman , ... M. Scott Harris , M.D., Chief Medical Officer.  In ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
Cached News: